Skip to main content
PUBLICATIONS
TOPICS
GUIDELINES
SUBSCRIBE
AUTHORS
ABOUT
CAREERS
Search
SHOPPING CART WITH
0
ITEM
LOG IN

ASCO’s publications—including the Society’s flagship publication, the Journal of Clinical Oncology—serve readers as the most credible, authoritative, peer-reviewed resources for significant clinical oncology research that informs the delivery of high-quality patient care across the globe.

Latest from our Journals
JCO CLINICAL CANCER INFORMATICS
ORIGINAL REPORTS DEC 23, 2025
Geospatial Analysis of Commission on Cancer-Accredited Centers Within Cancer Care Utilization–Based Catchment Areas
Nicole Rademacher et al.
JCO CLINICAL CANCER INFORMATICS
Open Access
ORIGINAL REPORTS DEC 23, 2025
Dynamic Mortality Risk Prediction in Myelodysplastic Syndromes Using Longitudinal Clinical Data
Jonathan Bobak et al.
JCO GLOBAL ONCOLOGY
Open Access
ORIGINAL REPORTS DEC 23, 2025
Linking Microbiome Diversity and Immune Profiles in Ethiopian Patients With Cervical Cancer
Kyoko Yoshida-Court et al.
JCO GLOBAL ONCOLOGY
Open Access
ORIGINAL REPORTS DEC 23, 2025
Risk Factors for Unresected Gastric Adenocarcinoma in South Africa: A National Cancer Registry Analysis
Naeelah Parker et al.
JCO GLOBAL ONCOLOGY
Open Access
SPECIAL ARTICLES DEC 23, 2025
Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk Neuroblastoma
Gabriela I. Villanueva et al.
JCO GLOBAL ONCOLOGY
Open Access
ORIGINAL REPORTS DEC 23, 2025
Feasibility of Providing Colorectal Cancer Screening in the Context of Door-to-Door Vaccination Activities in Mexico City
Priscilla Espinosa-Tamez et al.
JCO GLOBAL ONCOLOGY
Open Access
ORIGINAL REPORTS DEC 23, 2025
Adaptive Clinical Neuroblastoma Risk Groups—Tailoring Treatment in Low- and Middle-Income Countries: An International Neuroblastoma Risk Group Project
Wendy B. London et al.
JCO GLOBAL ONCOLOGY
Open Access
ORIGINAL REPORTS DEC 23, 2025
Cocreating Change: Stakeholder Engagement in Advancing Equitable Cancer Screening in India
Ishu Kataria et al.

Skip slideshow
ANNOUNCEMENTS
Explore the new AI-powered guidelines tool from ASCO and Google Cloud.
ASCO Launches New Open Access Journal JCO Oncology Advances
Explore the new AI-powered guidelines tool from ASCO and Google Cloud.
ASCO Launches New Open Access Journal JCO Oncology Advances
Explore the new AI-powered guidelines tool from ASCO and Google Cloud.
ASCO Launches New Open Access Journal JCO Oncology Advances
TRENDING ARTICLES
MOST CITED
JOURNAL OF CLINICAL ONCOLOGY
Open Access
CLINICAL TRIAL UPDATES JUN 03, 2025
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma
Sundar Jagannath et al.
JOURNAL OF CLINICAL ONCOLOGY
Open Access
ORIGINAL REPORTS OCT 23, 2023
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
Funda Meric-Bernstam et al.
JOURNAL OF CLINICAL ONCOLOGY
Open Access
CLINICAL TRIAL UPDATES SEP 24, 2025
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma
Franck Morschhauser et al.
JOURNAL OF CLINICAL ONCOLOGY
Full Access
ASCO SPECIAL ARTICLES SEP 16, 2025
Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Guideline
Rachel B. Jimenez et al.
JOURNAL OF CLINICAL ONCOLOGY
Open Access
ORIGINAL REPORTS NOV 12, 2025
177Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study
Amar U. Kishan et al.
JOURNAL OF CLINICAL ONCOLOGY
Full Access
ASCO SPECIAL ARTICLES APR 10, 2025
Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update
Ko Un Park et al.
Podcasts
CANCER STORIES: THE ART OF ONCOLOGY DEC 23, 2025
Final Silence: The Weight of Unspoken Words
JCO PRECISION ONCOLOGY CONVERSATIONS DEC 17, 2025
FGFR3 Alteration Status and Immunotherapy in Urothelial Cancer
Dr. Rafeh Naqash, Dr. Shilpa Gupta
JCO ONCOLOGY PRACTICE PODCAST DEC 15, 2025
Patient-Centered Head and Neck Cancer Survivorship
Dr. Fumiko Chino, Dr. Talya Salz, Jeff White
ASCO GUIDELINES DEC 11, 2025
Management of Cancer During Pregnancy Guideline
Brittany Harvey, Dr. Ann Partridge, Dr. Alison Loren
VIEW ALL PODCASTS
ABOUT ASCO
A world where cancer is prevented or cured

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. Through research, education, and promotion of the highest-quality, equitable patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy.

READ MORE ABOUT ASCO
Our Journals
January 1, 2026
Volume 44
Issue 1
December 2025
Volume 21
Issue 12
2025
Volume 11
2025
Volume 9
2025
Volume 9
2025
Volume 2
Our Content
Topics
ACCESS TO CARE
Development of a Composite Measure to Identify Priority Areas of Need for Cancer Screening Interventions
By
David N. Karp et al.
Dec 05, 2025
Geospatial Analysis of Commission on Cancer-Accredited Centers Within Cancer Care Utilization–Based Catchment Areas
By
Nicole Rademacher et al.
Dec 23, 2025
Development and Evaluation of a Patient Portal Education Module for Pediatric Patients With Cancer and Caregivers
By
Luxshikka Canthiya et al.
Dec 15, 2025
VIEW ACCESS TO CARE
QUALITY OF CARE
Cost Utility of Geriatric Assessment and Management in Older Adults With Cancer: From Evidence to Implementation
By
Abu Taher et al.
Dec 02, 2025
Development of a Composite Measure to Identify Priority Areas of Need for Cancer Screening Interventions
By
David N. Karp et al.
Dec 05, 2025
Geospatial Analysis of Commission on Cancer-Accredited Centers Within Cancer Care Utilization–Based Catchment Areas
By
Nicole Rademacher et al.
Dec 23, 2025
VIEW QUALITY OF CARE
GASTROINTESTINAL CANCERS
Benefits, Harms, and Burden of Colorectal Cancer Screening Among Childhood Cancer Survivors Previously Treated With Abdominopelvic Radiation
By
Jennifer M. Yeh et al.
Dec 17, 2025
FOLFIRINOX for Locally Advanced Pancreatic Cancer: The Need for Individualized Strategies
By
Orhun Akdogan et al.
Dec 04, 2025
Reply to: “FOLFIRINOX for Locally Advanced Pancreatic Cancer: The Need for Individualized Strategies,” “Conversion Chemotherapy for Locally Advanced Pancreatic Carcinoma: FOLFIRINOX or Gemcitabine?,” and “Chemotherapy for Locally Advanced Pancreatic Cancer: The Dilemma of David Versus Goliath After NEOPAN”
By
Michel Ducreux et al.
Dec 04, 2025
VIEW GASTROINTESTINAL CANCERS
VIEW ALL TOPICS
Submit to JCO Journals

Have your cancer research make an impact with the world's oncologists and their patients.

LEARN MORE

JOURNALS

Journal of Clinical Oncology
JCO Oncology Practice
JCO Global Oncology
JCO Clinical Cancer Informatics
JCO Precision Oncology
JCO Oncology Advances

PUBLICATIONS

ASCO Educational Book
ASCO Daily News
ASCO Connection
The ASCO Post
ASCO Podcasts

CONTENT

Journal Podcasts
Topics
Meeting Abstracts
ASCO Guidelines

INFORMATION

Author Center
Subscriber Center
Permissions
Reprints
Advertise
E-Alerts
View My Profile
About ASCO Journals

 FOLLOW US

JCO_ASCO
JCOOP_ASCO
JCOGO_ASCO
JCOPO_ASCO
JCOCCI_ASCO
JCOOA_ASCO

ASCO

About ASCO
Press Center
Meetings & Education
Contact Us

ASCO WEBSITES

asco.org
ASCO Career Center
Conquer Cancer

American Society of Clinical Oncology

2318 Mill Road, Suite 800, Alexandria, VA 22314

© 2025 American Society of Clinical Oncology

Site Map  Terms of Use  Privacy Policy  Cookies
This site uses tracking technologies through the use of permanent cookies and web beacons/pixel tags. By default, cookies are set to “Allow all cookies.” If you continue to use this site, then you acknowledge our use of cookies. For additional information, including on how to change your cookie settings, please visit “Cookies Settings” and review our Privacy Policy and Terms of Use.
Settings Accept